AMR Action Fund β Full Portfolio
19 tracked investments Β· listed companies and verified rows first
Antabio is a clinical-stage biopharmaceutical company developing novel antibacterial treatments for drug-resistant, Gram-negative bacterial infections identified as critical priorities by the WHO and CDC, with a focus on life-threatening hospital-acquired infections.
BiotechHealthtech
Centauri Therapeutics is an immunotherapy company developing treatments for infectious diseases and oncology using its proprietary Alphamer technology, which redirects naturally existing antibodies against life-threatening diseases.
BiotechHealthtech
BiotechArlington, US
Jon Weidanz(Director and President)Debra Weidanz(CEO and Director)
Board seatMartin HeideckerΒ· per SEC Form D Β· $1.7M raise Β· filed Sep 2016
BiotechGaithersburg, US
Evan Loh(Director)Gregory L. Merril(Executive Officer, Director, Promoter)Jana Jensen(Director)Raymond L. Martz(Director)Carl R. Merril(Executive Officer, Director)
BoardJonathan Leff(Director)
Board seatMartin HeideckerΒ· per SEC Form D Β· $30M raise Β· filed Jun 2023
BiotechNew York, US
Jim Flynn(Director)Kieren Marr(Executive Officer, Director)
BoardJonathan Leff(Director)
Board seatMartin HeideckerΒ· per SEC Form D
Rgenta Therapeutics develops small molecule RNA modulation therapies through a discovery platform, aiming to create treatment options for patients with unmet medical needs across multiple therapeutic areas.
AI & Machine LearningBiotechDeep TechCambridge, US
Judith Li(Director)Debasish Roychowdhury(Director)Travis Wager(Co-founder, President and CSO)Sun Linghao(Director)Hualin Simon Xi(Executive Officer, Director)Zhiping Weng(Co-founder)
Board seatMartin HeideckerΒ· per SEC Form D Β· $38M raise Β· filed Mar 2021
BiotechHealthtechCambridge, US
Bernat Olle(Executive Officer, Director)Daniel Couto(Executive Officer)Mark Mullikin(Executive Officer)Jeffrey Silber(Executive Officer)Bharatt Chowrira(Director)Christopher Viehbacher(Director)
Board seatMartin HeideckerΒ· per SEC Form D
Developing ceftibuten-ledaborbactam etzadroxil, a clinical phase 3-ready oral beta-lactam/beta-lactamase inhibitor combination for complicated urinary tract infections.
Malvern, US
Board seatMartin HeideckerΒ· per SEC Form D
Developing a diagnostics platform using single-cell analysis and machine learning to rapidly identify bacterial pathogens and determine antibiotic susceptibility.
Peptilogics is a clinical-stage biotechnology company developing engineered peptide therapeutics, led by zaloganan (PLG0206), an anti-biofilm treatment for medical device-related infections.
BiotechHealthtechMedical DevicesPittsburg, US
Jonathan Steckbeck(Executive Officer, Director)
BoardStephan Dietrich(Director)
Telum Therapeutics is a drug discovery biotechnology company that uses synthetic biology and AI to engineer phage lytic enzymes (enzybiotics) as alternatives to traditional antibiotics.
AI & Machine LearningBiotechHealthtechNoΓ‘in, ES
BiotechRedwood City, US
Larry Kauvar(Chief Science Officer)Stefan Ryser(President and Chief Executive Officer)Geoff Dillon(Chief Business Officer)Elisabeth Whitney(Chief Operating Officer)Nora Mende(Chief Financial Officer)
PartnerJunjun GaoΒ· ledHenry SkinnerΒ· quoted
Obtained U.S.
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.